📰 Vitro Diagnostics News
Page 6 - Vitro Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vitro Diagnostics. Real-time updates on events, politics, business and more.
January 1, 2024
Needham & Company LLC reiterated their hold rating on shares of Surmodics (NASDAQ:SRDX – Free Report) in a report published on Wednesday, MarketBeat Ratings reports. A number of other research analysts have also recently issued reports on SRDX. Barrington Research reaffirmed an outperform rating and issued a $71.00 price target on shares of Surmodics in […]
December 28, 2023
/PRNewswire/ -- The "In Vitro Diagnostics (IVD) Analyzers: Global Market" report has been added to ResearchAndMarkets.coms offering. The global market for IVD...
December 19, 2023
As per the report by Fortune Business Insights, the Infectious Disease Point-of-care (POC) Diagnostics Market size is projected to reach USD 12.46 billion...
December 18, 2023
StockNews.com upgraded shares of Surmodics (NASDAQ:SRDX – Free Report) from a hold rating to a buy rating in a research report report published on Thursday. Several other equities analysts have also recently issued reports on the stock. Barrington Research boosted their target price on shares of Surmodics from $69.00 to $71.00 and gave the company […]
December 8, 2023
/PRNewswire/ -- The global in vitro diagnostics (IVD) market size is estimated to reach around USD 124.65 billion by 2032, increasing from USD 107.76 billion...
November 29, 2023
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Smart or AI In-Vitro Diagnostics Market Size, Share &...
November 29, 2023
Surmodics, Inc. (NASDAQ:SRDX – Get Free Report) saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 235,300 shares, an increase of 71.0% from the October 31st total of 137,600 shares. Based on an average daily volume of 63,100 shares, the short-interest ratio is […]
November 28, 2023
The U.S. Food and Drug Administration this week authorized the Personal Genome Service Genetic Health Risk (GHR) Report for BRCA1/BRCA2 (Selected
November 24, 2023
/PRNewswire/ -- The "microfluidic market for healthcare application is segmented by application (In-vitro diagnostics, pharmaceutical research, and drug...
November 21, 2023
Vitro Diagnostics Market – Global Industry Analysis and Forecast (2023-2029)